Macular hole and intravitreal injection of triamcinolone acetonide for macular edema due to central retinal vein occlusion
- PMID: 17534835
- DOI: 10.1177/112067210701700333
Macular hole and intravitreal injection of triamcinolone acetonide for macular edema due to central retinal vein occlusion
Abstract
Purpose: To report a case of macular hole progression after intravitreal injection of triamcinolone acetonide (IVTA) for chronic macular edema secondary to nonischemic central retinal vein occlusion (CRVO).
Methods: A 33-year-old woman with massive macular edema after CRVO underwent IVTA. Optical coherence tomography (OCT) and fluorescein angiography were performed before and after the procedure.
Results: At the 1-week IVTA injection control, the patient's best-corrected visual acuity improved from 20/400 to 20/200 and OCT detected a progression of macular hole stage.
Conclusions: IVTA steroid injection may provide a significant improvement in macular edema, but injection-related complications may occur such as this uncommon macular reaction resulting in permanent visual loss.
Similar articles
-
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d. Retina. 2011. PMID: 21293319 Clinical Trial.
-
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131. Arch Ophthalmol. 2004. PMID: 15302652
-
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.Retina. 2005 Oct-Nov;25(7):846-50. doi: 10.1097/00006982-200510000-00005. Retina. 2005. PMID: 16205562
-
Noninfectious endophthalmitis following intravitreal triamcinolone acetonide: clinical case and literature review.Can J Ophthalmol. 2020 Dec;55(6):471-479. doi: 10.1016/j.jcjo.2020.06.002. Epub 2020 Jul 20. Can J Ophthalmol. 2020. PMID: 32702307 Review.
-
Controversies in intravitreal triamcinolone acetonide use.Int Ophthalmol Clin. 2005 Fall;45(4):133-41. doi: 10.1097/01.iio.0000176353.56990.3b. Int Ophthalmol Clin. 2005. PMID: 16199972 Review. No abstract available.
Cited by
-
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007324. doi: 10.1002/14651858.CD007324.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Sep 09;(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. PMID: 19160332 Free PMC article. Updated.
-
Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy.Int Ophthalmol. 2018 Apr;38(2):549-556. doi: 10.1007/s10792-017-0490-x. Epub 2017 Mar 15. Int Ophthalmol. 2018. PMID: 28299498
-
Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.Int J Ophthalmol. 2012;5(6):759-70. doi: 10.3980/j.issn.2222-3959.2012.06.20. Epub 2012 Dec 18. Int J Ophthalmol. 2012. PMID: 23275914 Free PMC article.
-
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.Cochrane Database Syst Rev. 2015 Sep 9;2015(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. Cochrane Database Syst Rev. 2015. PMID: 26352007 Free PMC article.
-
Macular hole progression after intravitreal bevacizumab for hemicentral retinal vein occlusion.Case Rep Ophthalmol Med. 2011;2011:679751. doi: 10.1155/2011/679751. Epub 2012 Jan 31. Case Rep Ophthalmol Med. 2011. PMID: 22606470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
